Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants

Metabolism: Clinical and Experimental

Volumn 46, Issue 8, 1997, Pages 959-962

  Ono, Hiroaki ^a   Sakamoto, Akiko ^a   Eguchi, Takaatsu ^a   Fujita, Naoto ^a   Nomura, Shinji ^a   Ueda, Haruo ^a   Sakura, Nobuo ^a   Ueda, Kazuhiro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FOLIC ACID; HOMOCYSTEINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; EPILEPSY; FOLIC ACID DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOSIS;

EID: 0030744636     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90087-1     Document Type: Article

References (17)

1. Reynolds EH: Chronic antiepileptic toxicity: A review. Epilepsia 16:319-352, 1975
2. Ueland PM, Refsum H: Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 144:473-501, 1989
3. Kang S-S, Wong PWK, Norusis M: Homocysteinemia due to folate deficiency. Metabolism 36:458-462, 1987
4. Stabler SP, Marcell PD, Podell ER, et al: Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 81:466-474, 1988
5. Ubbink JB, van der Merwe A, Delport R, et al: The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest 98:177-184, 1996
6. Cornwell PE, Morgan SL, Vaughn WH: Modification of a high-performance liquid chromatographic method for assay of homocysteine in human plasma. J Chromatogr 617:136-139, 1993
7. Kishi T, Eguchi T, Fujita N, et al: Serum folic acid in epileptics with a monotherapy of anti-epileptic drugs (in Japanese with English abstract). J Jpn Pediatr Soc 97:1593-1598, 1993
8. Hendel J, Dam M, Gram L, et al: The effects of carbamazepine and valproate on folate metabolism in man. Acta Neurol Scand 69:226-231, 1984
9. Billings RE: Decreased hepatic 5,10-methylenetetrahydrofolate reductase activity in mice after chronic phenytoin treatment, Mol Pharmacol 25:459-466, 1984
10. Carl GF, Smith DB: The effect of chronic phenytoin treatment on tissue folate concentrations and on the activities of the methyl synthetic enzymes in the rat. J Nutr 113:2368-2374, 1983
11. Arakawa T, Honda Y, Narisawa K: Mechanism of decrease in serum folate levels of rats receiving diphenylhydantoin. Tohoku J Exp Med 111:203-210, 1973
12. Stampfer MJ, Malinow R, Willett WC, et al: A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992
13. Perry IJ, Refsum H, Morris RW, et al: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395-1398, 1995
14. Motulsky AG: Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58:17-20, 1996
15. Mudd SH, Levy HL, Skovby F: Disorders of transsulfuration, in Charles RS, Arthur LB, William SS, et al (eds): The Metabolic and Molecular Bases of Inherited Disease (ed 7). New York, NY, McGraw-Hill, 1995, pp 1279-1327
16. Marangos PJ, Loftus T, Wiesner J, et al: Adenosinergic modulation of homocysteine-induced seizures in mice. Epilepsia 31:239-246, 1990
17. Mudd SH, Skovby F, Levy HL, et al: The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37:1-31, 1985